World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
146
Citations
117921
World Ranking
1312
National Ranking
64

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Andreas Hochhaus is affiliated with Friedrich Schiller University Jena in Germany and has a significant body of research in medicine, particularly focused on hematological malignancies. Their work covers a wide range of subfields including hematology, genetics, molecular biology, oncology, and rheumatology. The main topics of their research include chronic myeloid leukemia treatments, chronic lymphocytic leukemia research, and acute myeloid leukemia research.

Hochhaus has contributed extensively to the literature on chronic myeloid leukemia and related disorders. Their research appears frequently in leading hematology and oncology journals.

Frequent publication venues for their work include:

  • Leukemia
  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • HemaSphere
  • Journal of Cancer Research and Clinical Oncology

They have collaborated repeatedly with several researchers, often co-authoring papers with:

  • Jorge E. Cortés
  • Michael J. Mauro
  • Timothy P. Hughes
  • Thomas Ernst
  • Susanne Saußele

Recent notable papers authored or co-authored by Andreas Hochhaus include:

  • "European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia," 2020, Leukemia
  • "Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis," 2021, Leukemia
  • "A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs," 2021, Blood
  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms," 2022, Leukemia
  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms," 2022, Leukemia

Their research covers topics such as:

  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Acute Lymphoblastic Leukemia Research
  • HER2/EGFR in Cancer Research

Best Publications

  • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

    Stephen G. O'Brien;François Guilhot;Richard A. Larson;Insa Gathmann

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

    Giuseppe Saglio;Dong-Wook Kim;Surapol Issaragrisil;Gabriel Etienne

  • Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial

    Helmut Oettle;Peter Neuhaus;Andreas Hochhaus;Jörg Thomas Hartmann

  • Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.

    Hagop Kantarjian;Neil P. Shah;Andreas Hochhaus;Jorge Cortes

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

    Hagop M Kantarjian;Francis Giles;Lydia Wunderle;Kapil Bhalla

  • Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia

    Tim P. Hughes;Jaspal Kaeda;Susan Branford;Zbigniew Rudzki

  • Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

    Moshe Talpaz;Richard T. Silver;Brian J. Druker;John M. Goldman

  • Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

    Thomas Ernst;Andrew J Chase;Andrew J Chase;Joannah Score;Joannah Score;Claire E Hidalgo-Curtis;Claire E Hidalgo-Curtis

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    Andreas Hochhaus;Michele Baccarani;Richard T. Silver;Charles A. Schiffer

  • Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.

    A. Hochhaus;S. Kreil;A. S. Corbin;P. La Rosée;P. La Rosée

  • Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

    Andreas Hochhaus;Richard A. Larson;François Guilhot;Jerald P. Radich

  • Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

    Amy V. Jones;Sebastian Kreil;Katerina Zoi;Katherine Waghorn

  • Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

    Timothy P Hughes;Michael W Deininger;Andreas Hochhaus;Susan Branford

Frequent Co-Authors

Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Timothy P. Hughes
Timothy P. Hughes South Australian Health and Medical Research Institute
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Giuseppe Saglio
Giuseppe Saglio University of Turin
Michele Baccarani
Michele Baccarani University of Bologna
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Andreas Reiter
Andreas Reiter Heidelberg University
Michael W. Deininger
Michael W. Deininger University of Utah
Neil P. Shah
Neil P. Shah University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals today have access to an expanding array of related online degrees and flexible career pathways. Whether you are beginning your academic journey or seeking advanced qualifications, online programs can offer convenience, affordability, and accessibility.

For those interested in nutrition or food science, exploring the best online food science degree options can open doors to emerging fields like dietetics, wellness coaching, and public health nutrition. Working adults looking to move into healthcare management may benefit from finding whats the best online mha program for working adults, which often features flexible schedules and leadership-focused curricula.

Registered nurses seeking advancement without traditional clinical requirements can consider reputable rn to bsn programs without clinicals to expand their scope of practice online. Additionally, advanced practitioners may fast-track their careers through the fastest dnp online program options, designed for efficiency and busy professionals.

These pathways underscore the diverse opportunities available to students and working adults pursuing healthcare careers in flexible, online formats.

Best Scientists Citing Andreas Hochhaus

Trending Scientists